EICHOR
● Completed
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
Condition: Dry Eye Disease · Sponsor: Hoffmann-La Roche
About this study
This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye® or Xiidra®), in participants with dry eye disease (DED) compared to healthy volunteers (control participants).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (8)
| Eye Research Foundation | Newport Beach, California, United States | — |
| Butchertown Clinical Trials | Louisville, Kentucky, United States | — |
| Andover Eye Associates | Andover, Massachusetts, United States | — |
| Oculus Research | Garner, North Carolina, United States | — |
| CORE Inc. | Shelby, North Carolina, United States | — |
| Advancing Vision Research, LLC | Goodlettsville, Tennessee, United States | — |
| Total Eyecare, P.A. | Memphis, Tennessee, United States | — |
| Piedmont Eye Center | Lynchburg, Virginia, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07025811